Alquest Inc. Support Yields Vital BLA Clearance For Olympus America
10/19/2005 5:09:07 PM
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 11, 2005--Alquest - the leading contract research organization (CRO) specializing in medical devices and biologics -- recently helped its client, Olympus America, earn a vital clearance for a BLA (biologics license application). After providing program management and development support, Alquest was gratified to learn that the BLA was cleared by the U.S. Food and Drug Administration (FDA) without a single data point questioned or challenged.
comments powered by